Ross Moat
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ross Moat
Ross Moat is recorded as COO at Kiniksa Pharmaceuticals International, plc (KNSA). Kiniksa Pharmaceuticals International, plc reported in an 8-K filed January 14, 2026 that Ross Moat was appointed Chief Operating Officer and principal operating officer, effective January 10, 2026. Ross Moat has spoken on 2 earnings calls and 4 other investor events across 1 company, most recently for Kiniksa Pharmaceuticals International, plc on September 9, 2026.
“Effective January 10, 2026, the Board of Directors of Kiniksa Pharmaceuticals International, plc (the "Company") appointed Ross Moat to the position of Chief Operating Officer and principal operating officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Kiniksa Pharmaceuticals International, plc (KNSA)
Proxy statement
Start not stated–2025-04-21
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kiniksa Pharmaceuticals International, plc
Other people whose current roles at this company are on record from its filings.
- Sanj K. Patel CEO, Board Member
- Mark Ragosa CFO
- Michael Megna Chief Accounting Officer
- Barry D. Quart Board Member
- Felix J. Baker Board Member
- G. Bradley Cole Board Member
- Kimberly J. Popovits Board Member
- M. Cantey Boyd Board Member
- Richard S. Levy Board Member
- Stephen R. Biggar Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.